title: Novel factor Xa and plasma kallikrein inhibitory-activities of the second Kunitz-type inhibitory domain of urinary trypsin inhibitor.
abstract: Urinary trypsin inhibitor is a glycoprotein with a structure in which two Kunitz-type inhibitory domains are linked in a row. We isolated two genes encoding the 70 amino acid sequence from the 78th amino acid (Thr) to the C-terminal and the 68 amino acid sequence from the 80th (Ala) to the C-terminal of human urinary trypsin inhibitor, both which correspond to the second Kunitz-type inhibitory domain, and then constructed expression plasmids by ligating it to the E. coli alkaline phosphatase signal peptide gene. These plasmids under the control of the tryptophan promoter expressed the second domain in E. coli strain JE5505 which lacks the membrane lipoprotein. The recombinant second domain purified from the culture supernatant of the transformant inhibited trypsin, plasmin, leukocyte elastase and chymotrypsin which are known to be inhibited by urinary trypsin inhibitor. In addition it inhibited blood coagulation factor Xa and plasma kallikrein in a concentration dependent and competitive manner, and significantly prolonged the plasma-based activated partial thromboplastin time (APTT). The truncated natural counterpart obtained by a limited degradation of human urinary trypsin inhibitor also revealed the identical inhibitory activities.
authors.affiliation: Biosciences Research Laboratory, Mochida Pharmaceutical Co. Ltd., Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Morishita
authors.forename: T
authors.initials: T
authors.lastname: Yamakawa
authors.forename: T
authors.initials: T
authors.lastname: Matsusue
authors.forename: T
authors.initials: T
authors.lastname: Kusuyama
authors.forename: R
authors.initials: R
authors.lastname: Sameshima-Aruga
authors.forename: J
authors.initials: J
authors.lastname: Hirose
authors.forename: A
authors.initials: A
authors.lastname: Nii
authors.forename: T
authors.initials: T
authors.lastname: Miura
authors.forename: M
authors.initials: M
authors.lastname: Isaji
authors.forename: R
authors.initials: R
authors.lastname: Horisawa-Nakano
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D018076:DNA, Complementary / Q000235:genetics; D004926:Escherichia coli; D065427:Factor Xa Inhibitors; D005796:Genes; D006023:Glycoproteins / Q000096:biosynthesis / Q000737:chemistry* / Q000235:genetics; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors*; D008969:Molecular Sequence Data; D010314:Partial Thromboplastin Time; D017434:Protein Structure, Tertiary; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000737:chemistry; D014361:Trypsin Inhibitors / Q000096:biosynthesis / Q000737:chemistry* / Q000235:genetics
chemical_list: D018076:DNA, Complementary; D065427:Factor Xa Inhibitors; D006023:Glycoproteins; D011993:Recombinant Fusion Proteins; D014361:Trypsin Inhibitors; D007610:Kallikreins; C028665:urinastatin